retatrutide eli lilly ESC 2024: improves lipid and cardiovascular risk profile in Phase II trial Weight Loss: Lilly's New Drug

Enteric dysbiosis-linked gut barrier disruption triggers early renal injury induced by chronic high salt feeding in mice

I now aim for 140 grams per day, relying on go-to options like cottage cheese, shredded chicken, steak, and even protein coffee

GLP-1 and bariatric coverage may vary by policy, employer group, and prior authorization requirements

While GLP-1 medications were originally developed for Type II diabetes management, they are now widely used for metabolic health and weight management in non-diabetic patients who have obesity, insulin resistance, or weight loss resistance

Since it looks like average weight loss is 25% or more, its right in line with sleeve gastrectomy, says Dr